Background illustration for clinical trials search

Glomerulonephritis Clinical Trials

Browse 72 glomerulonephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

for
Focal Segmental Glomerulosclerosis
Location: East Providence RI, Mineola NY, Clifton Park NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 12+

Code: NCT07220083

Phase3, Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus, Lupus Nephritis
Location: Boston MA, Worcester MA, Montreal, Philadelphia PA,
Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 65

Code: NCT06121297

Phase1, Phase2, Recruiting

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

for
SIOD, Cystinosis, FSGS, SLE Nephritis, CKD Stage 4
Location: Palo Alto CA
Sponsor: Alice Bertaina

Sex: All

Age: 1 - 30

Code: NCT05508009

Phase1, Phase2, Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV),
Location: New York NY, Philadelphia PA, Durham NC, Miami FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT06308978

Phase1, Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

for
Immunoglobulin A Nephropathy (IgAN)
Location: Boston MA, Providence RI, The Bronx NY, Montreal,
Sponsor: Biogen

Sex: All

Age: 18+

Code: NCT06935357

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Canadian Glomerulonephritis Registry and Translational Research Initiative

for
Glomerular Nephritis
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18 - 70+

Code: NCT03460054

Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

for
Focal Segmental Glomerulosclerosis,
Location: Quebec, The Bronx NY, New York NY, Montreal,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT06500702

Phase2, Recruiting

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

for
Sequelae of; Infection, Post Infection Glomerulonephritis,
Location: Rockville MD
Sponsor: All Natural Medicine Clinic, LLC

Sex: All

Age: 0+

Code: NCT04846010

Phase1, Phase2, Recruiting

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

for
Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases,
Location: New York NY, Clifton Park NY, Orlando FL, Toronto,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06858319

Phase3, Recruiting

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

for
IgA Nephropathy
Location: Pembroke Pines FL, Orlando FL, Houston TX, Denver CO,
Sponsor: Jade Biosciences, Inc.

Sex: All

Age: 18 - 60

Code: NCT07541287

Phase2, Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

for
IgAN, C3G, Complement-mediated Kidney Disease,
Location: Great Neck NY, Shelby MI, Iowa City IA, Shreveport LA,
Sponsor: ADARx Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06989359

Phase2, Recruiting

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

for
Immunoglobulin A Nephropathy
Location: Boston MA
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06952426

Recruiting